Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.37 |
| ▸ | LCK | P06239 | 1/20 | 0.37 |
| ▸ | FYN | P06241 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL5083333 | 0.80 | FFAR3 (0.33) | FFAR3LCKFYN | |
| Acetic Acid SCHEMBL9240467 | 0.79 | FFAR3 (0.37) | FFAR3LCKFYN | |
| Acetic Acid SCHEMBL9223254 | 0.78 | FFAR3 (0.32) | FFAR3LCKFYN | |
| Acetic Acid SCHEMBL19834918 | 0.77 | FFAR3 (0.35) | FFAR3LCKFYN | |
| Acetic Acid SCHEMBL10866192 | 0.73 | FFAR3 (0.32) | FFAR3LCKFYN | |
| SCHEMBL9852788 | 0.72 | — | — | |
| SCHEMBL9852791 | 0.72 | — | — | |
| Acetic Acid SCHEMBL1766189 | 0.72 | FFAR3 (0.30) | FFAR3LCKFYN | |
| Acetic Acid SCHEMBL6535003 | 0.72 | AKR1B1 (0.34) | — | |
| SCHEMBL8651775 | 0.71 | TSHR (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2618807-B1 | ANTIMICROBIAL COMPOSITIONS CONTAINING CATIONIC ACTIVE INGREDIENTS AND QUATERNARY SUGAR DERIVED SURFACTANTS | ECOLAB USA INC (US) | 2020-03-11 | — | — | EP | disclosed |
| EP-3461334-A1 | ANTIMICROBIAL COMPOSITIONS CONTAINING CATIONIC ACTIVE INGREDIENTS AND QUATERNARY SUGAR DERIVED SURFACTANTS | Ecolab USA Inc. (US) | 2019-04-03 | — | — | EP | disclosed |
| US-9545461-B2 | Anti-microbial peptides and methods of use thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-01-17 | — | — | US | disclosed |
| US-9474703-B2 | Antimicrobial compositions containing cationic active ingredients and quaternary sugar derived surfactants | ECOLAB USA INC. (US) | 2016-10-25 | — | — | US | disclosed |
| US-20160151534-A1 | ANTI-MICROBIAL PEPTIDES AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2016-06-02 | — | — | US | disclosed |
| US-9187541-B2 | Anti-microbial peptides and methods of use thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-11-17 | — | — | US | disclosed |
| US-20150087717-A1 | ANTIMICROBIAL COMPOSITIONS CONTAINING CATIONIC ACTIVE INGREDIENTS AND QUATERNARY SUGAR DERIVED SURFACTANTS | ECOLAB USA INC (US) | 2015-03-26 | — | — | US | disclosed |
| US-8933055-B2 | Antimicrobial compositions containing cationic active ingredients and quaternary sugar derived surfactants | ECOLAB USA INC. (US) | 2015-01-13 | — | — | US | disclosed |
| US-20140221273-A1 | Anti-Microbial Peptides and Methods of Use Thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-08-07 | — | — | US | disclosed |
| EP-2618807-A2 | ANTIMICROBIAL COMPOSITIONS CONTAINING CATIONIC ACTIVE INGREDIENTS AND QUATERNARY SUGAR DERIVED SURFACTANTS | Ecolab USA Inc. (US) | 2013-07-31 | — | — | EP | disclosed |
| WO-2012148720-A2 | ANTI-MICROBIAL PEPTIDES AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-11-01 | — | — | WO | disclosed |
| WO-2012038915-A2 | ANTIMICROBIAL COMPOSITIONS CONTAINING CATIONIC ACTIVE INGREDIENTS AND QUATERNARY SUGAR DERIVED SURFACTANTS | ECOLAB USA INC. (US) | 2012-03-29 | — | — | WO | disclosed |
| US-20120071438-A1 | ANTIMICROBIAL COMPOSITIONS CONTAINING CATIONIC ACTIVE INGREDIENTS AND QUATERNARY SUGAR DERIVED SURFACTANTS | ECOLAB USA INC. (US) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071438-A1 | ANTIMICROBIAL COMPOSITIONS CONTAINING CATIONIC ACTIVE INGREDIENTS AND QUATERNARY SUGAR DERIVED SURFACTANTS | CUTA, UGCG, LGALS7; LGALS7B | FFAR3 224/4885LCK 657/4885FYN 2636/4885 |
| US-20150087717-A1 | ANTIMICROBIAL COMPOSITIONS CONTAINING CATIONIC ACTIVE INGREDIENTS AND QUATERNARY SUGAR DERIVED SURFACTANTS | CUTA, UGCG, LGALS7; LGALS7B | FFAR3 224/4885LCK 657/4885FYN 2636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.